Insider Trading July 6, 2026 05:30 PM

Arteris CEO Janac Disposes of $7.42M in Stock Amid Strong Q1 Earnings and Sector Expansion

Executive transactions include direct sales for tax obligations and indirect dispositions under a 10b5-1 plan, while the company reports revenue beats and strategic AI partnerships.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
AIP

K. Charles Janac, President and Chief Executive Officer of Arteris, Inc. (NASDAQ:AIP), executed a series of stock transactions on July 2, 2026, totaling approximately $7.42 million. The transactions comprised both direct sales to cover tax liabilities and indirect dispositions through a pre-arranged trading plan. Despite the executive's sales, Arteris reported strong first-quarter financial results for 2026, with earnings per share and revenue surpassing analyst expectations. The company continues to expand its footprint in the automotive and AI sectors through new licensing agreements and technology implementations.

Arteris CEO Janac Disposes of $7.42M in Stock Amid Strong Q1 Earnings and Sector Expansion
AIP
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Arteris CEO K. Charles Janac sold 203,588 shares worth $7.42 million on July 2, 2026, including direct sales for tax liabilities and indirect sales under a 10b5-1 plan.
  • The company reported strong Q1 2026 financial results, with EPS of -$0.03 beating estimates of -$0.07 and revenue of $22.94 million surpassing the $21.03 million forecast.
  • Arteris continues to expand its presence in the AI and automotive sectors through new licensing agreements with SiEngine Technology and technology implementations in Li Auto Inc.'s L9 Livis SUV.

K. Charles Janac, President and Chief Executive Officer of Arteris, Inc. (NASDAQ:AIP), executed a series of stock transactions on July 2, 2026, totaling approximately $7.42 million. The transactions comprised both direct sales to cover tax liabilities and indirect dispositions through a pre-arranged trading plan. Despite the executive's sales, Arteris reported strong first-quarter financial results for 2026, with earnings per share and revenue surpassing analyst expectations. The company continues to expand its footprint in the automotive and AI sectors through new licensing agreements and technology implementations.

On July 2, 2026, Mr. Janac directly sold 10,902 shares of Arteris common stock at a price of $38.7779 per share. These specific transactions were executed to satisfy tax liabilities arising from the release of restricted stock units. The company's policy mandates a "sell to cover" approach for such events, indicating these were not discretionary trades. Following these direct sales, Mr. Janac retained ownership of 185,827 shares of Arteris common stock.

In addition to the direct sales, Mr. Janac facilitated the indirect sale of 192,686 shares through Bayview Legacy, LLC. As the manager of this entity, Mr. Janac holds voting and dispositive power over the assets. These indirect sales were carried out under a pre-arranged 10b5-1 trading plan adopted on December 12, 2025. The prices for these transactions fell within a broader range of $34.77 to $43.24 per share. After these transactions, Bayview Legacy, LLC holds 8,555,047 shares of Arteris common stock. Mr. Janac also maintains an indirect holding of 56,252 shares through the Charles and Lydia Janac Trust, where he serves as trustee.

The total disposition of shares by Mr. Janac involved 203,588 shares, with prices ranging from $34.77 to $43.24 per share. This activity occurred as the stock price declined 26% over the past week to close at $34.82. Despite this recent decline, the stock remains up 280% over the past year. According to InvestingPro analysis, which provides comprehensive insights on over 1,400 US stocks, Arteris appears overvalued at current levels relative to its Fair Value estimate.

Amid the executive transactions, Arteris Inc. reported impressive financial results for the first quarter of 2026. The company reported earnings per share of -$0.03, surpassing the anticipated -$0.07. Revenue also exceeded expectations, reaching $22.94 million compared to the forecasted $21.03 million. Following this strong performance, TD Cowen raised its price target for Arteris shares to $40 from $22, maintaining a Buy rating. The firm highlighted the company's growth in AI and automotive sectors as key drivers.

Arteris has also announced a significant agreement with SiEngine Technology, licensing its FlexNoC network-on-chip interconnect IP for a new automotive system-on-chip platform. This collaboration builds on an existing relationship where SiEngine has used Arteris technology across multiple automotive chip generations. Additionally, Li Auto Inc. has implemented Arteris technology in its L9 Livis SUV, utilizing FlexNoC 5 NoC interconnect IP and Magillem SoC integration automation software for its autonomous driving system.

Northland maintains a market perform rating for Intel Corp., noting the company's progress in server CPU technology. These developments reflect ongoing advancements and collaborations in the technology and automotive sectors. The stock price data shows Arteris closed at $34.82, down $0.24 or 0.68%, with after-hours trading at $34.50, down $0.32 or 0.91%.

Risks

  • Arteris appears overvalued at current levels relative to its Fair Value estimate according to InvestingPro analysis, suggesting potential downside risk for investors.
  • The stock has declined 26% over the past week to $34.82, indicating recent volatility and potential short-term pressure despite long-term gains.

More from Insider Trading

Director Mark Hancock Executes $7.3 Million PACS Group Sale Under Pre-Arranged Plan Jul 6, 2026 PACS Group Executive Trims Holdings Amid Strong Financial Performance Jul 6, 2026 Kinder Morgan Executive Disposes of Shares Under Pre-Arranged Plan Jul 6, 2026 Joby Aviation CEO JoeBen Bevirt Offloads $140K in Shares to Cover Tax Obligations Jul 6, 2026 Charles Schwab Executive Jonathan Beatty Offloads Shares Under Pre-Arranged Plan Jul 6, 2026